These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 11005488)
1. Apoptosis in rectal cancer: prognostic significance in comparison with clinical histopathologic, and immunohistochemical variables. Schwandner O; Schiedeck TH; Bruch HP; Duchrow M; Windhoevel U; Broll R Dis Colon Rectum; 2000 Sep; 43(9):1227-36. PubMed ID: 11005488 [TBL] [Abstract][Full Text] [Related]
2. p53 and Bcl-2 as significant predictors of recurrence and survival in rectal cancer. Schwandner O; Schiedeck TH; Bruch HP; Duchrow M; Windhoevel U; Broll R Eur J Cancer; 2000 Feb; 36(3):348-56. PubMed ID: 10708936 [TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of p21 and p27 protein, apoptosis, clinical and histologic factors in rectal cancer without lymph node metastases. Schwandner O; Bruch HP; Broll R Eur Surg Res; 2002; 34(6):389-96. PubMed ID: 12403937 [TBL] [Abstract][Full Text] [Related]
4. The prognostic value of spontaneous apoptosis, Bax, Bcl-2, and p53 in oral squamous cell carcinoma of the tongue. Xie X; Clausen OP; De Angelis P; Boysen M Cancer; 1999 Sep; 86(6):913-20. PubMed ID: 10491515 [TBL] [Abstract][Full Text] [Related]
5. p21, p27, cyclin D1, and p53 in rectal cancer: immunohistology with prognostic significance? Schwandner O; Bruch HP; Broll R Int J Colorectal Dis; 2002 Jan; 17(1):11-9. PubMed ID: 12018448 [TBL] [Abstract][Full Text] [Related]
6. Coexpression of Bcl-2, c-Myc, and p53 oncoproteins as prognostic discriminants in patients with colorectal carcinoma. Bhatavdekar JM; Patel DD; Ghosh N; Chikhlikar PR; Trivedi TI; Suthar TP; Doctor SS; Shah NG; Balar DB Dis Colon Rectum; 1997 Jul; 40(7):785-90. PubMed ID: 9221853 [TBL] [Abstract][Full Text] [Related]
7. Apoptosis and its correlation with proliferative activity in rectal cancer. Kim YH; Lee JH; Chun H; Nam SJ; Lee WY; Song SY; Kwon OJ; Hyun JG; Sung IK; Son HJ; Rhee PL; Kim JJ; Paik SW; Rhee JC; Choi KW J Surg Oncol; 2002 Apr; 79(4):236-42. PubMed ID: 11920781 [TBL] [Abstract][Full Text] [Related]
8. Apoptosis in epithelial ovarian tumours Prognostic significance of clinical and histopathologic factors and its association with the immunohistochemical expression of apoptotic regulatory proteins (p53, bcl-2 and bax). de la Torre FJ; García A; Gil-Moreno A; Planaguma J; Reventos J; Ramón y Cajal S; Xercavins J Eur J Obstet Gynecol Reprod Biol; 2007 Jan; 130(1):121-8. PubMed ID: 16876311 [TBL] [Abstract][Full Text] [Related]
9. Prognostic value of Bax, Bcl-2, p53, and TUNEL staining in patients with radically resected ampullary carcinoma. Santini D; Tonini G; Vecchio FM; Borzomati D; Vincenzi B; Valeri S; Antinori A; Castri F; Coppola R; Magistrelli P; Nuzzo G; Picciocchi A J Clin Pathol; 2005 Feb; 58(2):159-65. PubMed ID: 15677536 [TBL] [Abstract][Full Text] [Related]
10. Low BAX protein expression correlates with disease recurrence in preoperatively irradiated rectal carcinoma. Nehls O; Okech T; Hsieh CJ; Sarbia M; Borchard F; Gruenagel HH; Gaco V; Porschen R; Gregor M; Klump B Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):85-91. PubMed ID: 15629598 [TBL] [Abstract][Full Text] [Related]
11. The significance of tumor markers for proliferation and apoptosis in predicting survival in colorectal cancer. Hilska M; Collan YU; O Laine VJ; Kössi J; Hirsimäki P; Laato M; Roberts PJ Dis Colon Rectum; 2005 Dec; 48(12):2197-208. PubMed ID: 16400510 [TBL] [Abstract][Full Text] [Related]
12. Clinical significance of mdm2 and p53 expression in bladder cancer. A comparison with cell proliferation and apoptosis. Shiina H; Igawa M; Shigeno K; Yamasaki Y; Urakami S; Yoneda T; Wada Y; Honda S; Nagasaki M Oncology; 1999 Apr; 56(3):239-47. PubMed ID: 10202280 [TBL] [Abstract][Full Text] [Related]
13. Apoptosis in breast carcinoma. González-Cámpora R; Galera Ruiz MR; Vázquez Ramírez F; Ríos Martín JJ; Fernández Santos JM; Ramos Martos MM; Gómez Pascual A Pathol Res Pract; 2000; 196(3):167-74. PubMed ID: 10729921 [TBL] [Abstract][Full Text] [Related]
14. Bcl-2, bax and p53 expression in rectal adenocarcinoma. Correlation with classic pathologic prognostic factors and patients' outcome. Tsamandas AC; Kardamakis D; Petsas T; Zolota V; Vassiliou V; Matatsoris T; Kalofonos H; Vagianos CE; Scopa CD In Vivo; 2007; 21(1):113-8. PubMed ID: 17354623 [TBL] [Abstract][Full Text] [Related]
15. The prognostic significance of p53 and bcl-2 expression in lung adenocarcinoma and its correlation with Ki-67 growth fraction. Ishida H; Irie K; Itoh T; Furukawa T; Tokunaga O Cancer; 1997 Sep; 80(6):1034-45. PubMed ID: 9305703 [TBL] [Abstract][Full Text] [Related]
16. The Bcl-2 protein: a prognostic indicator strongly related to p53 protein in lymph node-negative breast cancer patients. Silvestrini R; Veneroni S; Daidone MG; Benini E; Boracchi P; Mezzetti M; Di Fronzo G; Rilke F; Veronesi U J Natl Cancer Inst; 1994 Apr; 86(7):499-504. PubMed ID: 8133533 [TBL] [Abstract][Full Text] [Related]
17. Clinicopathologic and prognostic significance of matrix metalloproteinases in rectal cancer. Schwandner O; Schlamp A; Broll R; Bruch HP Int J Colorectal Dis; 2007 Feb; 22(2):127-36. PubMed ID: 16896992 [TBL] [Abstract][Full Text] [Related]
18. Prognostic value of apoptosis in breast cancer (pT1-pT2). A TUNEL, p53, bcl-2, bag-1 and Bax immunohistochemical study. Sirvent JJ; Aguilar MC; Olona M; Pelegrí A; Blázquez S; Gutiérrez C Histol Histopathol; 2004 Jul; 19(3):759-70. PubMed ID: 15168338 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of prognosis for malignant rectal gastrointestinal stromal tumor by clinical parameters and immunohistochemical staining. Changchien CR; Wu MC; Tasi WS; Tang R; Chiang JM; Chen JS; Huang SF; Wang JY; Yeh CY Dis Colon Rectum; 2004 Nov; 47(11):1922-9. PubMed ID: 15622586 [TBL] [Abstract][Full Text] [Related]
20. High survivin expression is associated with reduced apoptosis in rectal cancer and may predict disease-free survival after preoperative radiochemotherapy and surgical resection. Rödel F; Hoffmann J; Grabenbauer GG; Papadopoulos T; Weiss C; Günther K; Schick C; Sauer R; Rödel C Strahlenther Onkol; 2002 Aug; 178(8):426-35. PubMed ID: 12240548 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]